Search Results for:Carl O'Donnell
Three members of Tesla’s board will now weigh whether it is advisable – or even feasible – to pursue what could be the biggest-ever go-private deal, and they are doing so before receiving a formal proposal from the CEO.
The board expects to make a decision on whether to launch a formal review of Musk’s proposal in the coming days and is speaking to investment bankers about hiring financial advisers to assist it in its review in such scenario.
Son is optimistic that U.S. President Donald Trump’s escalation of trade disputes and heightened scrutiny of foreign investments would not affect the Japanese firm’s prolific deal-making.
This is the companies’ third attempt to clinch a deal in the last four years.
The deal comes after Aetna’s $37 billion plan to acquire smaller U.S. health insurance peer Humana Inc was blocked in January by a U.S. federal judge over antitrust concerns.
The move could result in slashing payments to fund managers
A deal could value the entire company at over $9 billion.
The earlier agreed deal value was $1.3 billion.
Pfizer Inc, beating out numerous other bidders, said it agreed to buy U.S. cancer drug company Medivation Inc for $14 billion in cash, adding its blockbuster prostate cancer drug Xtandi to the company’s growing oncology roster. Medivation shares jumped nearly 20 percent to close at $80.42, just shy of the offer… Read more »
Specialty pharmaceutical company Endo International Plc has held discussions with private equity firms about potential asset sales as it seeks to reduce its more than $8 billion debt pile, according to people familiar with the matter. The move underscores the challenges facing the Dublin-based company, which has seen its shares drop… Read more »